Format

Send to

Choose Destination
Expert Rev Clin Pharmacol. 2009 Nov;2(6):585-7. doi: 10.1586/ecp.09.43.

How open innovation could reinvigorate the pharmaceutical industry with fresh R&D opportunities.

Author information

1
Vice President Global Exploratory Development, UCB New Medicines, Chemin du Foriest, B-1420 Braine-l'Alleud, Belgium. thomas.senderovitz@ucb.com ; www.ucb.com.
PMID:
22112253
DOI:
10.1586/ecp.09.43

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center